Beijing Tiantan Biological Products Q3 Net Profit Falls 30.65% Y/Y
The company reported a 30.65% year-over-year decline in Q3 net profit.
Related stories
BOJ Says ETF Holdings Sales Would Take About 43 Years
The BOJ says completing sales of its ETF holdings would take about 43 years, down from a previous estimate of about 112 years.
L impact | EQUITY | Oct 30, 2026, 03:08 AM UTC
Nikkei futures extend losses, down 2.8% at 62,910
Nikkei futures were down 2.8% at 62,910, versus a 2.5% decline previously, after the BOJ outcome.
M impact | EQUITY | Oct 30, 2026, 03:07 AM UTC
Nikkei Futures Extend Decline, Down 2.9% After BOJ Decision
M impact | EQUITY | Oct 30, 2026, 03:07 AM UTC
Q2 Results Live Updates: Suzlon, Trent react to numbers; RIL, Sun Pharma, BEL, report today
Q2 Results Live Updates: The final trading day of the week will bring in a plethora of result reactions and plenty of earnings as well from Nifty 50 and broader market companies. R
H impact | EQUITY | Oct 30, 2026, 03:06 AM UTC
BOJ to Sell ETF Holdings at About 0.1% of Market Trading Value
M impact | EQUITY | Oct 30, 2026, 03:03 AM UTC
Nikkei Futures Down 2.6% After BOJ Decision
Nikkei futures were last down 2.6%, largely unmoved by the BOJ decision.
M impact | EQUITY | Oct 30, 2026, 03:03 AM UTC